In contrast, miR-106a is upregulated in BC tissue compared to its adjacent tissue, and in vitro models showed that the downregulation of this miRNA reduced BCL-2 and ATP-binding cassette super-family G member 2 (ABCG2), enhancing CIS sensitivity [77]. Here, BCL2 is linked to breast cancer.